Revenio Financial Statements From 2010 to 2025

REG1V Stock  EUR 26.64  0.12  0.45%   
Revenio financial statements provide useful quarterly and yearly information to potential Revenio Group investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Revenio financial statements helps investors assess Revenio's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Revenio's valuation are summarized below:
Revenio Group does not presently have any trending fundamental ratios for analysis.
Check Revenio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Revenio's main balance sheet or income statement drivers, such as , as well as many indicators such as . Revenio financial statements analysis is a perfect complement when working with Revenio Valuation or Volatility modules.
  
This module can also supplement various Revenio Technical models . Check out the analysis of Revenio Correlation against competitors.

Revenio Group Company Return On Equity Analysis

Revenio's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Revenio Return On Equity

    
  0.26  
Most of Revenio's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Revenio Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Revenio Group has a Return On Equity of 0.2575. This is 101.07% lower than that of the Health Care Equipment & Supplies sector and 103.85% lower than that of the Health Care industry. The return on equity for all Finland stocks is 183.06% lower than that of the firm.

Revenio Group Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Revenio's current stock value. Our valuation model uses many indicators to compare Revenio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Revenio competition to find correlations between indicators driving Revenio's intrinsic value. More Info.
Revenio Group is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about  0.55  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Revenio Group is roughly  1.81 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Revenio by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Revenio's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Revenio Financial Statements

Investors use fundamental indicators, such as Revenio's revenue or net income, to determine how well the company is positioned to perform in the future. Although Revenio's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Revenio Group Oyj, a health technology company, designs, manufactures, and sells medical instruments used for measuring intraocular pressure and bone density in Finland and rest of Europe, and internationally. The company serves general practitioners, opticians, optometrists, first-aid staff, and the field workers of aid organizations, as well as health care personnel working with child patients and in the vet clinics. Revenio Group operates under Medical Equipment classification in Finland and is traded on Helsinki Exchange. It employs 53 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Revenio Stock

Revenio financial ratios help investors to determine whether Revenio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Revenio with respect to the benefits of owning Revenio security.